Institutions / Elmind Capital, LP
Elmind Capital, LP
CIK 2052213 · Institution · as of Dec 31, 2025
Portfolio value
$338.85M
Positions
34
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 34 →
| Company | Value | % of portfolio |
|---|---|---|
| Cogent Biosciences, Inc. | $41.58M | 12.3% |
| Syndax Pharmaceuticals Inc | $38.97M | 11.5% |
| Viridian Therapeutics, Inc. | $26.72M | 7.9% |
| Vera Therapeutics, Inc. | $24.43M | 7.2% |
| Celldex Therapeutics, Inc. | $23.49M | 6.9% |
| CG Oncology, Inc. | $20.45M | 6.0% |
| Biocryst Pharmaceuticals Inc | $16.77M | 4.9% |
| Vaxcyte, Inc. | $13.45M | 4.0% |
| Beam Therapeutics Inc. | $13.20M | 3.9% |
| Pharvaris N.V. | $13.20M | 3.9% |
| KalVista Pharmaceuticals Inc | $12.94M | 3.8% |
| Dynavax Technologies Corp | $10.46M | 3.1% |
| Tyra Biosciences, Inc. | $9.20M | 2.7% |
| Nurix Therapeutics, Inc. | $8.73M | 2.6% |
| Wave Life Sciences Ltd | $7.61M | 2.2% |
| MBX Biosciences, Inc.MBX | $6.65M | 2.0% |
| Krystal Biotech, Inc. | $5.42M | 1.6% |
| United Therapeutics Corp | $5.36M | 1.6% |
| BioMarin Pharmaceutical Inc | $4.87M | 1.4% |
| Relay Therapeutics, Inc. | $4.54M | 1.3% |
| Travere Therapeutics, Inc. | $4.20M | 1.2% |
| Protagonist Therapeutics Inc | $3.32M | 1.0% |
| Cullinan Therapeutics, Inc. | $3.21M | 0.9% |
| Liquidia CorpLQDA | $3.10M | 0.9% |
| CytomX Therapeutics, Inc. | $2.98M | 0.9% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.